Tests RedCord therapy for bowel problems in people with multiple sclerosis
Tests a RedCord device against standard care for bowel problems in adults with multiple sclerosis.
Plain-language title generated from the registry record
Registry title: RedCord in Neurogenic Bowel Dysfunction in Multiple Sclerosis
Key facts
- Where
- Toledo, SpainSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 30 to 60 with multiple sclerosis. It tests Redcord therapy for bowel problems caused by nerve damage.
- Age
- 30 to 60 years
- Sex
- Women and men can join.
- Disease stage
- Multiple sclerosis diagnosed by McDonald's criteria, with an EDSS score below 6 points.
Main reasons for not taking part
- Cognitive impairment that makes it hard to understand the questionnaires
- Pregnant women
- Severe psychological or psychiatric illness that has been diagnosed
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 60 years old?
Source: NCT06838624, who can take part
Where in Spain
- University of Castilla La MachaToledo, SpainNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Castilla-La Mancha
- Trial code
- NCT06838624
- Record updated
- 24 February 2025
- Original description
The study aims to evaluate the effectiveness of Redcord treatment for neurogenic bowel dysfunction in patients with multiple sclerosis. The main objectives are:Read full original descriptionShow less
Effectiveness of Treatment With RedCord in Neurogenic Bowel Dysfunction in People With Multiple Sclerosis
The study aims to evaluate the effectiveness of Redcord treatment for neurogenic bowel dysfunction in patients with multiple sclerosis. The main objectives are:
* Assess the impact of Redcord on bowel function and quality of life in multiple sclerosis patients. * Compare the outcomes of Redcord treatment with standard care practices.
Participants will undergo Redcord therapy sessions and their bowel function will be monitored and compared to a control group receiving standard care. The study will measure improvements in bowel control, frequency, and overall patient satisfaction.
Inclusion: People diagnosed with Multiple Sclerosis according to McDonald's criteria; EDSS less than 6 points; Willingness to participate.
Exclusion: People with cognitive impairment, which makes it difficult to understand the questionnaires properly; Severe psychological or psychiatric pathology diagnosed; Pregnant women.